StockData
Twist Bioscience Corp logo

Twist Bioscience Corp (TWST) income statement

TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-K on Nov 16, 2026Score 13/30231% above fair value
$116.35+4.35 (+3.88%)

Close on Nov 18, 2026Market cap $7.30BP/E –Yield –

Twist Bioscience Corp income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
52.0%
Operating margin
-33.6%
Net margin
-31.7%
Return on equity, FY2025
-16.4%

Financial strength

Current ratio
2.67
Debt to equity
–
Debt to assets
–
Cash to current liabilities
97.7%

Valuation

P/E ratio
–
Price to sales
16.90
Price to book
16.37
Dividend yield
–

See a number that looks wrong?